Key result
Thiazide and allopurinol therapy achieves ~60% hypertension control in patients with metabolic urolithiasis risk.
Why the study?
The prevalence and treatment response of urolithiasis in hypertensive patients, particularly those with hypercalciuria and/or hyperuricosuria, required analysis to understand treatment outcomes.
What is the prevalence of urolithiasis in hypertensive patients, and does treatment with thiazides and/or allopurinol improve hypertension control in those with hypercalciuria and/or hyperuricosuria?
Cross-Sectional (n=900)
What is the prevalence of urolithiasis in hypertensive patients, and does treatment with thiazides and/or allopurinol improve hypertension control in those with hypercalciuria and/or hyperuricosuria?
Thiazides and allopurinol provide effective hypertension control in patients with concurrent urolithiasis driven by hypercalciuria or hyperuricosuria, supporting their continued use as first-line antihypertensive agents.
Answers are grounded in this paper and cite their sources.
May support targeted thiazide or allopurinol use in comorbid cases; hypothesis-generating and requires randomized confirmation before practice change.
In a group of 900 hypertensive patients we analyze the prevalence and the treatment response in the sub-group with urolithiasis. The prevalence of urolithiasis was 13,7%, and the prevalence of urolithiasis by hypercalciuria and/or hyperuricosuria was 12.3%. The control level to the treatment in the last sub-group with thiazides and/or allopurinol was 59,5%. The hypertensive patients with this type of urolithiasis and without hypertension control with this treatment were the intolerant patients to thiazides and/or allopurinol (6,3%) and the obese hypertensive patients (34,2%). These data help to explain why the thiazide diuretics have been the antihypertensive drugs that have given better results in the ALLHAT study and they still are continuing in the current recommendations like first line antihypertensive drugs
No takes yet. Share an insight, caveat, or question.
A 2006 study conducted a cross-sectional in Hypertension (n=900). Thiazides and/or allopurinol was evaluated on Prevalence of urolithiasis and hypertension control. In 900 hypertensive patients, urolithiasis prevalence was 13.7%, and hypertension control with thiazides and/or allopurinol in those with hypercalciuria or hyperuricosuria was 59.5%.
Synapse has enriched 10 related papers. Consider them for comparative context: